ID: ALA5190878

Max Phase: Preclinical

Molecular Formula: C29H49N2O10P

Molecular Weight: 616.69

Representations

Canonical SMILES:  CCCCCCCCCCCOc1cccc(CCC(=O)NC[C@@H](O)COP(=O)(O)OC[C@H](NC(C)=O)C(=O)OC)c1

Standard InChI:  InChI=1S/C29H49N2O10P/c1-4-5-6-7-8-9-10-11-12-18-39-26-15-13-14-24(19-26)16-17-28(34)30-20-25(33)21-40-42(36,37)41-22-27(29(35)38-3)31-23(2)32/h13-15,19,25,27,33H,4-12,16-18,20-22H2,1-3H3,(H,30,34)(H,31,32)(H,36,37)/t25-,27+/m1/s1

Standard InChI Key:  ZEXKNHLUVATLDE-VPUSJEBWSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 616.69

Molecular Weight (Monoisotopic): 616.3125

AlogP: 3.82

#Rotatable Bonds: 24

Polar Surface Area: 169.72

Molecular Species: ACID

HBA: 9

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 12

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 1.90

CX Basic pKa:

CX LogP: 3.54

CX LogD: 1.17

Aromatic Rings: 1

Heavy Atoms: 42

QED Weighted: 0.08

Np Likeness Score: -0.03

References

1. Sayama M, Uwamizu A, Ikubo M, Chen L, Yan G, Otani Y, Inoue A, Aoki J, Ohwada T..  (2021)  Switching Lysophosphatidylserine G Protein-Coupled Receptor Agonists to Antagonists by Acylation of the Hydrophilic Serine Amine.,  64  (14.0): [PMID:34233115] [10.1021/acs.jmedchem.1c00347]

Source

Source(1):

• Scientific Literature